{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T03:43:24Z","timestamp":1777952604174,"version":"3.51.4"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,9]]},"DOI":"10.7759\/cureus.81952","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T12:42:46Z","timestamp":1744202566000},"source":"Crossref","is-referenced-by-count":2,"title":["Survival and Hospital Discharge Achieved Through Intensive Circulatory, Fluid, and Respiratory Support in Severe TAFRO (Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis, and Organomegaly) Syndrome With Multiorgan Dysfunction: A Case Report"],"prefix":"10.7759","author":[{"given":"Yu","family":"Masui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Idei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Yokose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Takaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly [Article in Japanese]","volume":"51","author":"Takai K","year":"2010","unstructured":"Takai K, Nikkuni K, Shibuya H, Hashidate H. Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly [Article in Japanese]. Rinsho Ketsueki. 2010, 51:320-5.","journal-title":"Rinsho Ketsueki"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt.53.57","article-title":"Castleman-Kojima disease (TAFRO syndrome) : a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012)","volume":"53","author":"Kawabata H","year":"2013","unstructured":"Kawabata H, Takai K, Kojima M, et al.. Castleman-Kojima disease (TAFRO syndrome) : a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012). J Clin Exp Hematop. 2013, 53:57-61. 10.3960\/jslrt.53.57","journal-title":"J Clin Exp Hematop"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-016-1979-1","article-title":"Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version","volume":"103","author":"Masaki Y","year":"2016","unstructured":"Masaki Y, Kawabata H, Takai K, et al.. Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version. Int J Hematol. 2016, 103:686-92. 10.1007\/s12185-016-1979-1","journal-title":"Int J Hematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-022-04762-6","article-title":"Castleman disease and TAFRO syndrome","volume":"101","author":"Masaki Y","year":"2022","unstructured":"Masaki Y, Arita K, Sakai T, Takai K, Aoki S, Kawabata H. Castleman disease and TAFRO syndrome. Ann Hematol. 2022, 101:485-90. 10.1007\/s00277-022-04762-6","journal-title":"Ann Hematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-020-03008-3","article-title":"Optimal treatments for TAFRO syndrome: a retrospective surveillance study in Japan","volume":"113","author":"Fujimoto S","year":"2021","unstructured":"Fujimoto S, Kawabata H, Sakai T, et al.. Optimal treatments for TAFRO syndrome: a retrospective surveillance study in Japan. Int J Hematol. 2021, 113:73-80. 10.1007\/s12185-020-03008-3","journal-title":"Int J Hematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.14740\/jmc4160","article-title":"Stepwise treatment for TAFRO syndrome","volume":"14","author":"Ide M","year":"2023","unstructured":"Ide M, Yokoyama T, Ishikawa M, Kojima K. Stepwise treatment for TAFRO syndrome. J Med Cases. 2023, 14:369-77. 10.14740\/jmc4160","journal-title":"J Med Cases"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2015.1120389","article-title":"TAFRO syndrome successfully treated with tocilizumab: a case report and systematic review","volume":"28","author":"Sakai K","year":"2018","unstructured":"Sakai K, Maeda T, Kuriyama A, Shimada N, Notohara K, Ueda Y. TAFRO syndrome successfully treated with tocilizumab: a case report and systematic review. Mod Rheumatol. 2018, 28:564-9. 10.3109\/14397595.2015.1120389","journal-title":"Mod Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt.19021","article-title":"Epidemiological analysis of multicentric and unicentric Castleman disease and TAFRO syndrome in Japan","volume":"59","author":"Masaki Y","year":"2019","unstructured":"Masaki Y, Kawabata H, Fujimoto S, et al.. Epidemiological analysis of multicentric and unicentric Castleman disease and TAFRO syndrome in Japan. J Clin Exp Hematop. 2019, 59:175-8. 10.3960\/jslrt.19021","journal-title":"J Clin Exp Hematop"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006271","article-title":"A life-threatening case of TAFRO syndrome with dramatic response to tocilizumab, rituximab, and pulse steroids: the first case report in Latin America","volume":"96","author":"Jos\u00e9 FF","year":"2017","unstructured":"Jos\u00e9 FF, Kerbauy LN, Perini GF, et al.. A life-threatening case of TAFRO syndrome with dramatic response to tocilizumab, rituximab, and pulse steroids: the first case report in Latin America. Medicine (Baltimore). 2017, 96:e6271. 10.1097\/MD.0000000000006271","journal-title":"Medicine (Baltimore)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.18999\/nagjms.81.3.519","article-title":"Fatal case of TAFRO syndrome associated with over-immunosuppression: a case report and review of the literature","volume":"81","author":"Matsuhisa T","year":"2019","unstructured":"Matsuhisa T, Takahashi N, Nakaguro M, et al.. Fatal case of TAFRO syndrome associated with over-immunosuppression: a case report and review of the literature. Nagoya J Med Sci. 2019, 81:519-28. 10.18999\/nagjms.81.3.519","journal-title":"Nagoya J Med Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26292","article-title":"Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease","volume":"96","author":"Nishimura Y","year":"2021","unstructured":"Nishimura Y, Fajgenbaum DC, Pierson SK, et al.. Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease. Am J Hematol. 2021, 96:1241-52. 10.1002\/ajh.26292","journal-title":"Am J Hematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/343139-survival-and-hospital-discharge-achieved-through-intensive-circulatory-fluid-and-respiratory-support-in-severe-tafro-thrombocytopenia-anasarca-fever-reticulin-fibrosis-and-organomegaly-syndrome-with-multiorgan-dysfunction-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T12:42:47Z","timestamp":1744202567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/343139-survival-and-hospital-discharge-achieved-through-intensive-circulatory-fluid-and-respiratory-support-in-severe-tafro-thrombocytopenia-anasarca-fever-reticulin-fibrosis-and-organomegaly-syndrome-with-multiorgan-dysfunction-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.81952","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,9]]}}}